Macquarie Group’s Loxo Oncology, Inc LOXO Stock Holding History

Macquarie Group’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-68,000	Closed	-$9.53M	–	2306
2018 Q4	$9.53M	Hold	68,000	–	–	0.02%	605
2018 Q3	$11.6M	Hold	68,000	–	–	0.02%	609
2018 Q2	$11.8M	Sell	68,000 -200	-0.3%	-$30.1K	0.02%	602
2018 Q1	$7.87M	Sell	68,200 -727	-1%	-$77.3K	0.01%	661
2017 Q4	$5.8M	Buy	68,927 +17,927	+35%	+$1.49M	0.01%	751
2017 Q3	$4.7M	Hold	51,000	–	–	0.01%	767
2017 Q2	$4.09M	Buy	+51,000	New	+$2.83M	0.01%	798

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Macquarie Group's LOXO Position: Q1 2019 in Review

Macquarie Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 68,000 shares — an estimated $9.53M sold.

Macquarie Group first reported a position in LOXO in Q2 2017 and held it in 7 quarters. The position peaked at $11.8M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Macquarie Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Macquarie Group sold 68,000 Loxo Oncology, Inc shares in Q1 2019, an estimated $9.53M.
Macquarie Group first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 7 quarters.
Macquarie Group's Loxo Oncology, Inc position peaked at $11.8M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.